Crossmark

Interpreting the apparent benefit of thoracic radiotherapy in metastatic NSCLC: patient selection and analytical issues remain important—a comment on Xue et al

Crossref DOI link: https://doi.org/10.1007/s00432-026-06567-w

Published Online: 2026-07-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qin, Lili

Wang, Shasha

Qin, Haifeng
License Information

Text and Data Mining valid from 2026-07-27

Version of Record valid from 2026-07-27
More Information

Article History

Received: 30 June 2026

Accepted: 11 July 2026

First Online: 27 July 2026

Declarations

Conflict of interest: The authors declare no competing interests.

Ethical approval: As this article is a commentary on published meta-analysis data and does not involve original research with human participants, patient data, or animal subjects, no ethical approval was required.

Document is current

Any future updates will be listed below